FDA commissioner nominee Scott Gottlieb could fuse staff specialization ideas in the 21st Century Cures bill and user fee reauthorization to create a more modular personnel grouping of reviewers.
The idea could allow specialists in certain clinical or product issues to be accessed by reviewers or divisions when they...